← Back to Search

Laser Therapy

Femtosecond Laser Surgery for Astigmatism

N/A
Waitlist Available
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: ≥18 years of age
Sex: male or female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial is investigating the best laser settings to use for a type of cataract surgery that also corrects astigmatism.

Who is the study for?
This trial is for adults over 18 who need cataract surgery with astigmatism correction at the Schein Ernst Mishra Eye clinic. They must be fluent in English and plan to have their surgeries within 60 days of consultation, with any second eye surgery within 2-4 weeks of the first.Check my eligibility
What is being tested?
The study tests specific laser settings used during femtosecond laser-assisted cataract surgery combined with astigmatic keratotomy (AK). The goal is to refine these settings to improve future outcomes for patients undergoing this combined procedure.See study design
What are the potential side effects?
Potential side effects may include discomfort or vision issues related to the laser treatment, such as light sensitivity, glare, or temporary visual disturbances post-surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am either male or female.
Select...
I am scheduled for laser-assisted cataract surgery with astigmatism correction within 60 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Keratometric Correction Index
Refractive Correction Index

Trial Design

1Treatment groups
Experimental Treatment
Group I: Femto-AK PatientsExperimental Treatment1 Intervention
Femtosecond laser assisted cataract surgery with creation of astigmatic keratotomies for the correction of corneal astigmatism.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
489 Previous Clinical Trials
2,798,231 Total Patients Enrolled
2 Trials studying Cataract
115 Patients Enrolled for Cataract

Media Library

Femto-AK (Laser Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04676451 — N/A
Cataract Research Study Groups: Femto-AK Patients
Cataract Clinical Trial 2023: Femto-AK Highlights & Side Effects. Trial Name: NCT04676451 — N/A
Femto-AK (Laser Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04676451 — N/A
Cataract Patient Testimony for trial: Trial Name: NCT04676451 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor presently recruiting participants?

"The information found on clinicaltrials.gov discloses that this specific trial is not presently accepting participants. This research project was first posted to the website in May 2018 and its latest update arrived January 2022. Although inactive, there are 149 other active trials recruiting patients at this moment."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
What site did they apply to?
Penn State Hershey Eye Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

To help others who share a similar condition.
PatientReceived 1 prior treatment
~21 spots leftby Dec 2024